MEND syndrome
ORPHA:401973Mendelian susceptibility to mycobacterial diseases
ORPHA:748Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency
ORPHA:99898Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency
ORPHA:319547Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
ORPHA:319558Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
ORPHA:319552Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency
ORPHA:319563Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency
ORPHA:477857Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
ORPHA:319600Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
ORPHA:319595Meningeal melanocytoma
ORPHA:252046Meningioma
ORPHA:2495Meningocele
ORPHA:93968Meningococcal meningitis
ORPHA:33475Menke-Hennekam syndrome
ORPHA:592574Menkes disease
ORPHA:565Menstrual cycle-dependent periodic fever
ORPHA:498251Multiple endocrine neoplasia
ORPHA:276161Conductive deafness-malformed external ear syndrome
ORPHA:3216Multiple endocrine neoplasia type 1
ORPHA:652Multiple endocrine neoplasia type 2
ORPHA:653Multiple endocrine neoplasia type 2A
ORPHA:247698Multiple endocrine neoplasia type 2B
ORPHA:247709Multiple endocrine neoplasia type 4
ORPHA:2761523-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome
ORPHA:44503846,XX difference of sex development
ORPHA:298246,XX difference of sex development induced by androgens excess
ORPHA:9807846,XX difference of sex development induced by endogenous maternal-derived androgen
ORPHA:32509346,XX difference of sex development induced by exogenous maternal-derived androgen
ORPHA:32509946,XX difference of sex development induced by fetal androgens excess
ORPHA:9077646,XX difference of sex development induced by fetoplacental androgens excess
ORPHA:32506146,XX difference of sex development induced by maternal-derived androgen
ORPHA:9114446,XX difference of sex development-anorectal anomalies syndrome
ORPHA:297346,XX difference of sex development-skeletal anomalies syndrome
ORPHA:297546,XX disorder of gonadal development
ORPHA:32505546,XX ovotesticular difference of sex development
ORPHA:213846,XX testicular difference of sex development
ORPHA:39346,XY difference of sex development
ORPHA:9808546,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
ORPHA:75246,XY difference of sex development due to 5-alpha-reductase 2 deficiency
ORPHA:75346,XY difference of sex development due to a cholesterol synthesis defect
ORPHA:32551146,XY difference of sex development due to a defect in testosterone metabolism by peripheral tissue
ORPHA:9808646,XY difference of sex development due to a testosterone synthesis defect
ORPHA:9078346,XY difference of sex development due to adrenal and testicular steroidogenesis defect
ORPHA:9078646,XY difference of sex development due to impaired androgen production
ORPHA:32535746,XY difference of sex development due to isolated 17,20-lyase deficiency
ORPHA:9079646,XY difference of sex development due to testicular 17,20-desmolase deficiency
ORPHA:44308746,XY difference of sex development due to testicular steroidogenesis defect
ORPHA:90787